MaxCyte Inc
LSE:MXCT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
MaxCyte Inc
LSE:MXCT
|
US |
|
T
|
Toray Industries Inc
OTC:TRYIY
|
JP |
|
InspireMD Inc
F:II2
|
IL |
|
A
|
Aristocrat Leisure Ltd
XMUN:AC8
|
AU |
|
J
|
Jiangxi Copper Co Ltd
XMUN:JIX
|
CN |
|
Rupert Resources Ltd
XTSX:RUP
|
CA |
|
Covivio SA
PAR:COV
|
FR |
|
L
|
Lime Technologies AB (publ)
F:LTX
|
SE |
Wall St Price Targets
MXCT Price Targets Summary
MaxCyte Inc
According to Wall Street analysts, the average 1-year price target for MXCT is 4.35 GBX with a low forecast of 2.55 GBX and a high forecast of 5.45 GBX.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MXCT's stock price target?
Price Target
4.35
GBX
According to Wall Street analysts, the average 1-year price target for MXCT is 4.35 GBX with a low forecast of 2.55 GBX and a high forecast of 5.45 GBX.
What is the Revenue forecast for MaxCyte Inc?
Projected CAGR
32%
Over the last 12 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 8 years is 32%.
What is the Gross Profit forecast for MaxCyte Inc?
Projected CAGR
7%
Over the last 12 years, the compound annual growth rate for Gross Profit has been 13%. The projected CAGR for the next 2 years is 7%.
